Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A massive new study has mapped gene activity across 6.3 million brain cells in the prefrontal cortex, shedding light on how disorders like Alzheimer's, Parkinson's, and schizophrenia develop. Researchers found shared molecular signatures across multiple brain diseases and identified age 24 as a key stability milestone. The findings could help pinpoint better treatment targets for some of the brain's most devastating conditions.
Scientists have produced one of the most detailed maps ever of gene activity in the prefrontal cortex — the brain region responsible for decision-making, emotional regulation, and planning. Spanning nine studies published in Nature and other journals, the research analyzed over 6.3 million brain cell nuclei from 1,494 donors ranging from infancy to age 108, including people with Alzheimer's, Parkinson's, Lewy body dementia, schizophrenia, and bipolar disorder.
The map revealed striking molecular similarities across diseases. Alzheimer's, Lewy body disease, vascular dementia, and Parkinson's shared gene activity patterns tied to neuronal communication and blood-vessel biology, while Alzheimer's and Parkinson's also overlapped in microglial (brain immune cell) pathways. Notably, people who maintained cognitive function despite significant Alzheimer's pathology showed differences in energy-related cellular processes — offering clues to potential protective mechanisms.
By the Numbers:
Why it matters: This gene activity atlas gives researchers a powerful tool to distinguish normal aging from disease, identify vulnerable cell types, and zero in on the most promising targets for future treatments — a crucial step toward more personalized therapies for brain disorders.
